A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...